Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage.

Source:http://linkedlifedata.com/resource/pubmed/id/17501976

Download in:

View as

General Info

PMID
17501976